- The Washington Times - Wednesday, June 29, 2016

The Salk Institute has a new study that marijuana legalization advocates will be sure to pass around. 

As ScienceDaily.com reported on Wednesday, researchers there have found that chemicals in the plant such as THC “can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease.”

“Although other studies have offered evidence that cannabinoids might be neuroprotective against the symptoms of Alzheimer’s, we believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells,” the science-news website quoted Salk Institute Professor David Schubert from a research paper he published recently.

“Schubert emphasized that his team’s findings were conducted in exploratory laboratory models, and that the use of THC-like compounds as a therapy would need to be tested in clinical trials,” Science Daily noted.

 



Copyright © 2019 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide